CAR T-Cells Followed By CD34-Selected T-Cell Depleted (TCD) ALLO-HSCT is Associated with Low Toxicity and favorable overall survival

Fabrizio V.; Boulad F.; Cancio M.; Margossian S.; Mauguen A.; Prockop S.; Scaradavou M.; Shah N.; Spitzer B.; Stieglitz E.; Kernan N.; OReilly R.; Boelens J. J.; Curran K.

首页> 外文期刊>Pediatric blood & cancer >CAR T-Cells Followed By CD34-Selected T-Cell Depleted (TCD) ALLO-HSCT is Associated with Low Toxicity and favorable overall survival

【24h】

CAR T-Cells Followed By CD34-Selected T-Cell Depleted (TCD) ALLO-HSCT is Associated with Low Toxicity and favorable overall survival

机译：汽车T细胞随后是CD34 - 选择的T细胞耗尽（TCD）Allo-Hsct与低毒性和良好的整体存活相关

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2019年第s4期|共1页
作者
Fabrizio V.; Boulad F.; Cancio M.; Margossian S.; Mauguen A.; Prockop S.; Scaradavou M.; Shah N.; Spitzer B.; Stieglitz E.; Kernan N.; OReilly R.; Boelens J. J.; Curran K.;
展开▼
作者单位

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Dana Farber Boston Childrens Canc &

Blood Disorde Pediat Hematol Oncol Boston MA USA;

Mem Sloan Kettering Canc Ctr Epidemiol Biostat 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Yale Canc Ctr Pediat Hematol Oncol New Haven CT USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Univ Calif San Francisco Helen Diller Family Comprehens Canc Ctr Pediat Hematol Oncol San;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. CAR T-Cells Followed By CD34-Selected T-Cell Depleted (TCD) ALLO-HSCT is Associated with Low Toxicity and favorable overall survival [J] . Fabrizio V., Boulad F., Cancio M., Pediatric blood & cancer . 2019,第S4期

机译：汽车T细胞随后是CD34 - 选择的T细胞耗尽（TCD）Allo-Hsct与低毒性和良好的整体存活相关
2. CD34+Selected Ex-Vivo T-Cell Depleted (TCD) Grafts for Allogeneic Hematopoietic Cell Transplantation (Allo-HSCT) Is Associated with Low Incidence of Acute and Chronic Graft-Versus-Host Disease (GVHD) and High Chronic-Gvhd/Relapse-Free Survival [J] . Barba Pere, Hilden Patrick, Devlin Sean M., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：用于异基因造血细胞移植（Allo-HSCT）的CD34 +选定的前体T细胞衰竭（TCD）移植与急性和慢性移植物抗宿主病（GVHD）的发生率低和慢性Gvhd /复发高免费生存
3. T- Cell Depleted Peripheral Blood Stem Cell (TCD-PBSC) Transplants Secure Consistent Engraftment with Low Risk of Acute or Chronic Gvhd and Favorable Disease Free Survival (DFS) and Overall Survival (OS) for Pediatric Patients (< 21 years) with AML in CR1 [J] . Kernan Nancy A., Boulad Farid, Prockop Susan E., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：T细胞贫乏的外周血干细胞（TCD-PBSC）移植可确保始终如一的移植，对于患有AML的小儿患者（<21岁），急性或慢性Gvhd的风险低，无疾病生存期（DFS）和总体生存期（OS）低CR1
4. T-cell mimicry of streptococcal M protein and cardiac myosin epitopes by T-cell clones from rheumatic heart disease [C] . Nadia M.J. Ellis, Ya Li, William Hildebrand, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：动霉菌克隆来自风湿性心脏病的T细胞粘土蛋白和心肌肌蛋白表位的T细胞
5. Label-Free CD8+ T-Cell Purification and Electroporation in Relation to Car T-Cell Therapy [D] . Ringwelski, Beth Anne. 2020

机译：无标记的CD8 + T细胞纯化和电穿孔与汽车T细胞疗法有关
6. Ex Vivo CD34+ Selected T-Cell Depleted (TCD) Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease (GVHD) and High Treatment Response [O] . Pere Barba, Patrick Hilden, Sean M Devlin, -1

机译：急性白血病和骨髓增生异常综合征同种异体造血干细胞移植的离体CD34 +选择的T细胞耗竭（TCD）外周血干细胞移植与急性和慢性移植物抗宿主病（GVHD）的发生率低和治疗反应高相关
7. Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant [O] . Vanessa A. Fabrizio, Nancy A. Kernan, Farid Boulad, 2020

机译：在翻倒/难治性b-所有以下CAR T细胞和CD34所选T细胞耗尽的同种异体造血细胞移植中的低毒性和良好的整体存活

CAR T-Cells Followed By CD34-Selected T-Cell Depleted (TCD) ALLO-HSCT is Associated with Low Toxicity and favorable overall survival

著录项

相似文献

相关主题

期刊订阅